Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports

One of the most powerful weapons against COVID-19 is vaccines. After the worldwide spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also in children and adolescents aged 12–18. Since then, alarming reports of cases of myocarditis and/or pericarditis have been not...

Descripción completa

Detalles Bibliográficos
Autores principales: Piras, Alessandra, Melis, Giada, Cugusi, Lucia, Bassareo, Pier Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589994/
https://www.ncbi.nlm.nih.gov/pubmed/36278552
http://dx.doi.org/10.3390/pediatric14040048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589994/
https://www.ncbi.nlm.nih.gov/pubmed/36278552
http://dx.doi.org/10.3390/pediatric14040048

Ejemplares similares